Medical Devices Investors & VC Firms

1641 firms in this list, with a median first check of $500K. 343 of them lead rounds. Generated from verified public data and updated continuously.

Fund	FoxScore	HQ	Invests	Stage	Check	CRM
WH White Fund BFEBLLPS15 people	88🔒	Liège	BE	Seed–Series A	$2.2M – $5.4M	+ Add to CRM
FU Fund+ BDHNCGCB11 people	88🔒	Leuven	BE	Series A–Series B	$5.5M – $16.5M	+ Add to CRM
HE Health2047 LKGMJSJB17 people	88🔒	San Francisco	US	Seed	—	+ Add to CRM
EX Excel Venture Management JETBCWSG7 people	88🔒	Boston	US	Series A–Late Stage	$1M – $5M	+ Add to CRM
KE Kelvin Capital AHJMGWGM10 people	88🔒	Glasgow	GB	Seed–Growth	—	+ Add to CRM
PA Pathway to Cures LVTWTBAL19 people	88🔒	New York	US	Seed–Series A	—	+ Add to CRM
WE WELL Ventures HSAJASAK16 people	88🔒	Vancouver	CA	Seed–Series A	—	+ Add to CRM
BO Boomerang Ventures OMABDHEB9 people	88🔒	Indianapolis	US	Seed–Growth	$250K – $1.5M	+ Add to CRM
LB LBBW Venture Capital GmbH AVFMCLMN9 people	88🔒	Stuttgart	DE	Seed–Series A	$540K – $3.2M	+ Add to CRM
MA Martlet Capital IITHAWIG6 people	88🔒	Cambridge	GB	Pre-Seed–Series A	$317.5K	+ Add to CRM
CH China Growth Capital DCJL卢吴8 people · Leads rounds	88🔒	Beijing	CN	Seed–Series A	—	+ Add to CRM
TR Trans-Pacific Technology Fund AYBSMTNG17 people	88🔒	Taipei	TW	Seed–Growth	—	+ Add to CRM
BR Breakthrough Victoria BMDBIMJB7 people	88🔒	Melbourne	AU	Pre-Seed–Growth	—	+ Add to CRM
ME MemorialCare Innovation Fund CWBSBHD10 people · Leads rounds	88🔒	Long Beach	US	Seed–Series B	—	+ Add to CRM
GL Global Blockchain Ventures AWDMDKMH12 people	88🔒	Orlando	US	Series A	—	+ Add to CRM
ME MedMountain Ventures BRSJSTSP9 people · Follows rounds	88🔒	Salt Lake City	US	Pre-Seed–Series A	$500K – $5M	+ Add to CRM
BI Birchmere Ventures NRSASSMF5 people	88🔒	Pittsburgh	US	Seed–Series A	$500K – $5M	+ Add to CRM
CH Champel Capital AWABGEOB14 people	88🔒	Jerusalem	IL	Seed–Late Stage	—	+ Add to CRM
QU quadraScope Venture Fund FMDFFWLC17 people	88🔒	Boston	US	—	—	+ Add to CRM
PA PAI Partners AAKBAAWP13 people	88🔒	Paris	FR	Growth–Late Stage	$108M – $324M	+ Add to CRM
SA SATUS Venture Sp. z o.o. KBJKASSR7 people	88🔒	Kraków	PL	Pre-Seed–Series A	$108K – $6.5M	+ Add to CRM
SE Seroba Life Sciences AOADBMDO13 people	88🔒	Dublin	IE	Seed–Growth	$540K – $7.6M	+ Add to CRM
IN Incentive, Peregrine Ventures Incubator BLELLSD(12 people	88🔒	Or Yehuda	IL	Pre-Seed–Seed	—	+ Add to CRM
SA Sanara Capital ABASDKDB15 people	88🔒	Ra'anana	IL	Seed–Series B	—	+ Add to CRM

White Fund

LiègeSeed–Series A$2.2M – $5.4M

BFEBLLPS15 people

Fund+

LeuvenSeries A–Series B$5.5M – $16.5M

BDHNCGCB11 people

Health2047

San FranciscoSeed

LKGMJSJB17 people

Excel Venture Management

BostonSeries A–Late Stage$1M – $5M

JETBCWSG7 people

Kelvin Capital

GlasgowSeed–Growth

AHJMGWGM10 people

Pathway to Cures

New YorkSeed–Series A

LVTWTBAL19 people

WELL Ventures

VancouverSeed–Series A

HSAJASAK16 people

Boomerang Ventures

IndianapolisSeed–Growth$250K – $1.5M

OMABDHEB9 people

LBBW Venture Capital GmbH

StuttgartSeed–Series A$540K – $3.2M

AVFMCLMN9 people

Martlet Capital

CambridgePre-Seed–Series A$317.5K

IITHAWIG6 people

China Growth Capital

BeijingSeed–Series A

DCJL卢吴8 people

Trans-Pacific Technology Fund

TaipeiSeed–Growth

AYBSMTNG17 people

Breakthrough Victoria

MelbournePre-Seed–Growth

BMDBIMJB7 people

MemorialCare Innovation Fund

Long BeachSeed–Series B

CWBSBHD10 people

Global Blockchain Ventures

OrlandoSeries A

AWDMDKMH12 people

MedMountain Ventures

Salt Lake CityPre-Seed–Series A$500K – $5M

BRSJSTSP9 people

Birchmere Ventures

PittsburghSeed–Series A$500K – $5M

NRSASSMF5 people

Champel Capital

JerusalemSeed–Late Stage

AWABGEOB14 people

quadraScope Venture Fund

Boston

FMDFFWLC17 people

PAI Partners

ParisGrowth–Late Stage$108M – $324M

AAKBAAWP13 people

SATUS Venture Sp. z o.o.

KrakówPre-Seed–Series A$108K – $6.5M

KBJKASSR7 people

Seroba Life Sciences

DublinSeed–Growth$540K – $7.6M

AOADBMDO13 people

Incentive, Peregrine Ventures Incubator

Or YehudaPre-Seed–Seed

BLELLSD(12 people

Sanara Capital

Ra'ananaSeed–Series B

ABASDKDB15 people

Data sourced from public filings and firms' own websites — see our methodology.